These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 7171232)

  • 1. Current status of pertussis and pertussis vaccination in Finland.
    Mertsola J; Viljanen MK; Ruuskanen O
    Ann Clin Res; 1982 Dec; 14(5-6):253-9. PubMed ID: 7171232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-emergence of pertussis in Slovenia: time to change immunization policy.
    Grgic-Vitek M; Klavs I; Kraigher A
    Vaccine; 2008 Mar; 26(15):1874-8. PubMed ID: 18313178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
    Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of immunization against pertussis.
    Stuart-Harris C
    Dev Biol Stand; 1979; 43():75-83. PubMed ID: 520687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lifelong protection against pertussis].
    Riffelmann M; Wirsing von König CH
    Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S86-9. PubMed ID: 19353478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance of pertussis in the CSSR. IV. Immunological surveys of antibodies to pertussis and parapertussis in the Bohemian regions and in Slovakia in 1958 - 1971.
    Vysoká-Burianová B; Burian V; Maixnerová M; Prásilová K; Kríz B; Wernish Z; Zikmundová V; Kavanová M; Tĕmínová J; Richter J; Stehlik J; Paroulek J; Formánek J; Stejskalová M; Bezecná A; Bäumlová M; Zofka J; Strnad P; Zusková D; Zácek K
    J Hyg Epidemiol Microbiol Immunol; 1976; 21(2):229-47. PubMed ID: 184208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis: an update on primary prevention and outbreak control.
    Scott PT; Clark JB; Miser WF
    Am Fam Physician; 1997 Sep; 56(4):1121-8. PubMed ID: 9310064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
    Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
    Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiology of pertussis in industrialized countries].
    Baron S; Bégué P; Grimprel E
    Sante; 1994; 4(3):195-200. PubMed ID: 7921686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whooping cough in Finland 1920-1978. Statistical and epidemiological studies.
    Huovila R
    Acta Paediatr Scand Suppl; 1982; 298():1-29. PubMed ID: 6305107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action to be taken when facing one or more cases of whooping-cough].
    Floret D; Bonmarin I; Deutsch P; Gaudelus J; Grimprel E; Guérin N; Guiso N; Morer I
    Arch Pediatr; 2005 Aug; 12(8):1281-91. PubMed ID: 15961299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.